The metabolic response of the liver when acute experimental haemorrhagic shock is treated with dextran or gelatin-type plasma expanders.
D000818:Animals; D001794:Blood Pressure; D001810:Blood Volume; D002245:Carbon Dioxide / Q000097:blood; D003911:Dextrans / Q000627:therapeutic use*; D004285:Dogs; D005690:Galactose / Q000097:blood; D005780:Gelatin / Q000627:therapeutic use*; D006207:Half-Life; D006400:Hematocrit; D006454:Hemoglobins; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000097:blood; D008099:Liver / Q000378:metabolism*; D008722:Methods; D010100:Oxygen / Q000097:blood; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011773:Pyruvates / Q000097:blood; D012771:Shock, Hemorrhagic / Q000097:blood / Q000188:drug therapy*; D013448:Sulfobromophthalein / Q000097:blood; D013997:Time Factors; D014527:Uric Acid / Q000097:blood
D003911:Dextrans; D006454:Hemoglobins; D007773:Lactates; D010952:Plasma Substitutes; D011773:Pyruvates; D013448:Sulfobromophthalein; D002245:Carbon Dioxide; D014527:Uric Acid; D005780:Gelatin; D010100:Oxygen; D005690:Galactose